Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for NITAZOXANIDE
- Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication
- A Comparative Study Between Concomitant Versus Load Therapy in Eradication of Helicobacter Pylori Infection
- Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men
- Pharmacokinetic Interaction Between Nitazoxanide and Atazanavir/Ritonavir in Healthy Volunteers
- Effect of the Nutritional Support System on Neuromotor Alterations in Patients With Cerebral Palsy
- Clinical Study to Compare Efficacy and Safety of Casirivimab and Imdevimab Combination, Remdesivir and Favipravir in Hospitalized COVID-19 Patients
- Role of Nitazoxanide and Escitalopram in Patients With Rheumatoid Arthritis
- A Randomized Single-Blind Controlled Trial Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation
- Nitazoxanide Pharmacokinetic Parameters in Renal Impaired Subjects
- Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management
- Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness
- Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness
- Nitazoxanide Pharmacokinetic Parameters in Hepatic Impaired Patients
- Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)
- MANS-NRIZ Trial for COVID-19 Treatment : Extension Study
- Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection
- Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19
- Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts
- Nitazoxanide as a New Local Adjunctive to Nonsurgical Treatment of Moderate Periodontitis
- Nitazoxanide in Prevention of Secondary Spontaneous Peritonitis
- AGILE (Early Phase Platform Trial for COVID-19)
- EAT-DUTA AndroCoV Trial
- A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19
- Nitazoxanide Therapy for Patients With COVID-19 Pneumonia
- COVID-19 Prophylaxis South Africa (COVER HCW)
- Effects of Early Use of Nitazoxanide in Patients With COVID-19
- Catalysing the Containment of COVID-19
- Sofosbuvir/Ledipasvir and Nitazoxanide for Treatment of COVID-19
- Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection
- Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19
- Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)
- The Nitazoxanide Plus Atazanavir for COVID-19 Study
- Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients
- Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19
- Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19
- Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children
- Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide
- New Antiviral Drugs for Treatment of COVID-19
- Novel Regimens in COVID-19 Treatment
- Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection
- The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment
- Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19
- Remdesivir Efficacy in Coronavirus Disease
- Military COVID-19 Hydroxychloroquine Pre-exposure and Post-exposure Prophylaxis Study
- Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)
- Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19
- Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy
- Comparison Between Quadruple Regimens for Helicobacter Pylori Infection in Egypt
- Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B
- Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection
- Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis
- NNITS-Nitazoxanide for Norovirus in Transplant Patients Study
- A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosporidiosis
- A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza
- Early Life Interventions for Childhood Growth and Development In Tanzania
- A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis
- A Two Week Nitazoxanidebased Quadruple Regimen
- Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
- Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy
- Finding Better Treatment of Bronchiolitis: A Clinical Trial of Oral Nitazoxanide for the Treatment of Bronchiolitis in Infants Presenting to Hospital Emergency Departments
- Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori
- The Effects of Nitazoxanide in Hepatic Encephalopathy
- Oral Nitazoxanide in Acute Gastroenteritis in Australian Indigenous Children
- Nitazoxanide Versus Placebo for the Treatment of Hospitalized Subjects With Severe Acute Respiratory Illness
- Trial Comparing the Efficacy, Tolerability and Safety Between Three Arms in Treatment of HCV in Egyptian Population
- The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients
- Irritable Bowel Syndrome Evaluation and Treatment in Primary Care
- Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
- Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection
- Is it Effective to Treat Patients With Blastocystis Hominis Infection?
- Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children
- Nitazoxanide for the Treatment of Prolonged Diarrhea in Children
- Efficacy of Nitazoxanide in the Treatment of Chronic Hepatitis C Virus (HCV)
- Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
- Study of the Impact of Nitazoxanide on Chronic Hepatitis Patients
- A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures
- Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic Encephalopathy
- A Pilot Study to Examine the Role of Nitazoxanide to Prevent Recurrence of Hepatitis C After Transplantation
- Study of Nitazoxanide in Adults With Acute Uncomplicated Influenza
- Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
- 4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepatitis C
- Use of Nitazoxanide and Probiotics in Acute Diarrhea Secondary to Rotavirus
- Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients
- Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C
- Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C
- Study of Nitazoxanide in the Treatment of Chronic Hepatitis C
- Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis C
- Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis
- Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease
- Study of Nitazoxanide in the Treatment of Amebiasis in Children
- Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents
- Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection
- Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children
- Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease
- Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children
- Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients
- A Study of Nitazoxanide in the Treatment of AIDS-Related Diarrhea
- A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis
- A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium
Clinical trials list
click for details